Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 18, 2016 07:57 ET | Source: Biomerica

Biomerica Announces First Quarter Fiscal 2017 Financial Results, Sales Increase Over Prior Year

IRVINE, CA--(Marketwired - October 18, 2016) - Biomerica, Inc. (NASDAQ: BMRA), a global provider of advanced diagnostic products, today reported net sales of $1,410,110 for the three months ending...
October 04, 2016 07:57 ET | Source: Biomerica

Biomerica Highlights Recent Scientific Reports Indicating Increased Prevalence of IBS

IRVINE, CA--(Marketwired - October 04, 2016) - Biomerica, Inc. (NASDAQ: BMRA), a global provider of advanced diagnostic products, today emphasized the market opportunity created by global market...
September 06, 2016 07:47 ET | Source: Biomerica

Biomerica to Present at 18th Annual Rodman & Renshaw Global Investment Conference

IRVINE, CA--(Marketwired - September 06, 2016) - Biomerica, Inc. (NASDAQ: BMRA), a global provider of advanced diagnostic products, today announced that Zackary Irani, Chief Executive Officer, will...
August 30, 2016 09:29 ET | Source: Biomerica

Biomerica Announces Year End Results

IRVINE, CA--(Marketwired - August 30, 2016) - Biomerica, Inc. (NASDAQ: BMRA), a global provider of advanced diagnostic products, today reported net sales for the fiscal year 2016 were $5,139,816...
August 24, 2016 08:19 ET | Source: Biomerica

Biomerica Approved for Listing on the Nasdaq Capital Market

IRVINE, CA--(Marketwired - August 24, 2016) - Biomerica Inc. (OTCQB: BMRA) today announced that its common stock has been approved for listing on the Nasdaq Capital Market and is expected to...
August 10, 2016 09:25 ET | Source: Biomerica

Biomerica Updates Shareholders on Progress of Commercialization of Its New IBS Product

IRVINE, CA--(Marketwired - August 10, 2016) - Biomerica Inc. (OTCQB: BMRA) today announced that has issued an update on the progress of commercialization of its new IBS diagnostic guided therapy...
July 25, 2016 07:47 ET | Source: Biomerica

Biomerica Forms Strategic Advisory Board and Expands Scientific Advisory Board

IRVINE, CA--(Marketwired - July 25, 2016) - Biomerica Inc. (OTCQB: BMRA) today announced that it added Edward W. (Ned) Barnholt to a newly formed Strategic Advisory Board and Dr. Anthony J. Lembo to...
July 18, 2016 07:47 ET | Source: Biomerica

Biomerica Adds Dr. Mark Sirgo to Board of Directors

IRVINE, CA--(Marketwired - July 18, 2016) - Biomerica Inc. (OTCQB: BMRA) today announced that it has added Dr. Mark A. Sirgo to its Board of Directors, expanding the Board to six members which...
July 11, 2016 07:47 ET | Source: Biomerica

FDA Determines That Biomerica's Proposed InFoods(R) IBS Clinical Investigation Is a Nonsignificant Risk (NSR) Device Study

IRVINE, CA--(Marketwired - July 11, 2016) - Biomerica, Inc. (OTCQB: BMRA) announced today that the U.S. Food and Drug Administration (FDA) has determined that the proposed clinical study to validate...
May 26, 2016 09:09 ET | Source: Biomerica

Biomerica Signs Exclusive License Agreement for Korean Market With Total Value of up to $8.5 Million; Licensee Makes Equity Investment of $1m in Biomerica at $3 per Share

IRVINE, CA--(Marketwired - May 26, 2016) - Biomerica Inc. (OTCQB: BMRA) today announced that it has entered into an exclusive license agreement with Celtis Pharm Co. Ltd of South Korea granting...